Journal article icon

Journal article

Recent progress in the prevention of serogroup B meningococcal disease

Abstract:

The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge of providing protection against serogroup B disease. Over a period of four decades vaccine development has focused on sub-capsular, protein antigens, first with outer membrane vesicle (OMV) vaccines against epidemic outbreaks, and more recently on new multicomponent vaccines designed to offer better cross-protection against the antigenically diverse strains responsible for endemic disease. Beca...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1128/CVI.00566-16

Authors


More by this author
Institution:
University of Oxford
Oxford college:
Hertford College
Role:
Author
Publisher:
American Society for Microbiology
Journal:
Clinical and Vaccine Immunology More from this journal
Volume:
24
Issue:
5
Pages:
e00566-16
Publication date:
2017-03-29
Acceptance date:
2017-03-14
DOI:
EISSN:
1556-679X
ISSN:
1556-6811
Pubs id:
pubs:687495
UUID:
uuid:e91de9f9-8cd8-4cea-b8b1-2558fa356ad8
Local pid:
pubs:687495
Source identifiers:
687495
Deposit date:
2017-03-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP